Pulse biosciences, inc.PLSE.US Overview

US StockHealthcare

(No presentation for PLSE)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

PLSE Overall Performance

PLSE AI Analysis & Strategy

PLSE Recent Performance

1.38%

Pulse biosciences, inc.

0.81%

Avg of Sector

-1.14%

S&P500

PLSE PowerScanner

PLSE Key Information

PLSE Valuation Metrics

PLSE Earnings Table

PLSE Profile

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.